Catheter Precision, Inc. Common Stock VTAK 深 滬
等待開盤 12-17 09:30:00 美东时间
2.19
-0.045
-2.01%
華盛通- 最 高2.41
- 今 開2.41
- 成交量 4.07万股
- 最 低 2.00
- 昨 收 2.235
- 總市值 268.89万
- 52周最高 15.6807
- 市盈率 靜 --
- 換手率 3.31%
- 52周最低 1.4921
- 委 比 63.52%
- 總股本 122.78万
- 歷史最高 5225000.00
- 量 比 0.81
- 振 幅 18.34%
- 歷史最低 2.00
- 每 手 1
- 風險率 2.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Catheter Precision Launches LockeT Suture Retention Device In Switzerland
Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced the successful launch of
12-01 21:02
Catheter Precision, Inc. Common Stock Q3 EPS $(1.70) Misses $(0.11) Estimate, Sales $226.000K Miss $1.700M Estimate
Catheter Precision, Inc. Common Stock (AMEX:VTAK) reported quarterly losses of $(1.70) per share which missed the analyst consensus estimate of $(0.11) by 1445.45 percent. This is a 95.55 percent increase over losses of
11-14 05:40
Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland
Catheter Precision, Inc., a US-based medical device company, has signed a strategic distribution agreement with FuMedica AG, a leading Swiss distributor, to introduce its LockeT suture retention device to hospitals and clinics across Switzerland. LockeT is a Class 1 FDA-registered and CE-approved device designed to simplify vascular access site closure following cardiac procedures. FuMedica AG, renowned for its expertise in distributing advanced ...
10-16 12:00
Catheter Precision Increases Authorized Shares to 500 Million
An announcement from Catheter Precision ( ($VTAK) ) is now available. On Octobe...
10-16 04:54
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 32.1% to...
10-09 05:06
Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO
Catheter Precision, Inc. announced the allowance for two new patents from the USPTO. The first, "Methods of Ventricular Arrhythmia Localization Using a 3D Model," enhances the VIVO technology portfolio for Kardionav. The second, "Neurostimulation Devices and Methods," focuses on improving cardiac ventricular function, particularly for heart failure patients, under Cardionomix. CEO David Jenkins highlighted the importance of these patents in creat...
09-30 12:00
Catheter Precision Announces Tender Win and First Purchase Order in Croatia
Catheter Precision, Inc. announced it received its first purchase order from Dubrava University Hospital in Croatia following a competitive bid. The hospital's evaluation highlighted the effectiveness of the company's VIVO 3D imaging system, which aids in identifying the origin of ventricular arrhythmias. This marks a significant milestone for Catheter Precision, reflecting growing acceptance of its technology in Europe and underscoring its commi...
09-10 12:00
Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders
<p>Catheter Precision, Inc. announced that September 10, 2025, is the Record Date for its October 10, 2025, Special Meeting of stockholders. The meeting will seek stockholder approval to amend the Certificate of Incorporation to increase authorized common shares and appoint WithumSmith+Brown, PC as the independent auditor for fiscal 2026. A preliminary proxy statement is anticipated to be filed with the SEC on September 4, 2025.</p>
09-04 20:15
Catheter Precision Announces Introduction of the LockeT Product Line into Italy
Catheter Precision, Inc. announced the introduction of LockeT in Italy, following successful clinical evaluations in France and Germany. The first procedures in Italy were performed at ASST Valle Olona Hospital under the guidance of Dr. Manuela Bianchi. After a successful evaluation, the company received its first commercial purchase order from long-time partner Precise Srl. David Jenkins, CEO of Catheter Precision, expressed enthusiasm about Loc...
09-02 12:00
Catheter Precision Announces First Procedures in France as LockeT Expansion Continues
<p><p>FORT MILL, S.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US-based medical device company and leader in innovative cardiac electrophysiology solutions, announced the first LockeT procedures in France. This milestone demonstrates significant progress in the adoption and commercialization of its technologies across Europe. The procedures were successfully completed at CHU Rennes, led by Professor Ra...
08-28 12:00
